Published in Transfus Med Hemother on March 15, 2013
Blood cells: an historical account of the roles of purinergic signalling. Purinergic Signal (2015) 0.78
MitoQ regulates autophagy by inducing a pseudo-mitochondrial membrane potential. Autophagy (2017) 0.75
The gears keep turning: current progress in platelet function testing. Transfus Med Hemother (2013) 0.75
Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood (2016) 0.75
Anticoagulant action of low, physiologic, and high albumin levels in whole blood. PLoS One (2017) 0.75
Platelet alpha-granules: basic biology and clinical correlates. Blood Rev (2009) 2.72
P2 receptors, platelet function and pharmacological implications. Thromb Haemost (2008) 1.57
The role of ADP receptors in platelet function. Front Biosci (2006) 1.34
Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets. Exp Hematol (2001) 1.33
Inherited platelet disorders. Haemophilia (2012) 1.27
Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost (2011) 1.12
The platelet release reaction: just when you thought platelet secretion was simple. Curr Opin Hematol (2008) 1.10
Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. Eur J Pharmacol (1998) 1.06
The emerging value of P-selectin as a disease marker. Clin Chem Lab Med (2004) 1.06
Monitoring of clopidogrel action: comparison of methods. Clin Chem (2005) 1.04
Comparative study of platelet dense granule constituents. Am J Physiol (1982) 1.03
A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents. Br J Haematol (1995) 0.98
Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood (1990) 0.96
Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies. Stroke (2003) 0.96
Measurement of secretion of serotonin. Methods Enzymol (1989) 0.95
Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke (1991) 0.92
Platelet storage pool deficiency: diagnosis in patients with prolonged bleeding times and normal platelet aggregation. Br J Haematol (1990) 0.92
Platelet dense-granule secretion plays a critical role in thrombosis and subsequent vascular remodeling in atherosclerotic mice. Circulation (2009) 0.92
Platelet secretion from dense and alpha-granules in vitro in migraine with or without aura. J Neurol Neurosurg Psychiatry (1994) 0.91
Endogenous inhibitory mechanisms and the regulation of platelet function. Methods Mol Biol (2012) 0.89
Simultaneous detection of nucleotides, nucleosides and oxidative metabolites in myocardial biopsies. J Chromatogr B Biomed Appl (1996) 0.88
Congenital defects of platelet function. Platelets (2012) 0.87
The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays. Semin Thromb Hemost (2009) 0.87
A comparison of the serotonin and ATP content in platelets from subjects with Down's syndrome. Biochem Med (1974) 0.86
Simultaneous determination of adenosine triphosphate and its metabolites in human whole blood by RP-HPLC and UV-detection. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.86
Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase. Thromb Haemost (2011) 0.86
A sensitive HPLC-based method to quantify adenine nucleotides in primary astrocyte cell cultures. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.86
Low angle light scattering analysis: a novel quantitative method for functional characterization of human and murine platelet receptors. Clin Chem Lab Med (2012) 0.85
Phenotypic approaches to gene mapping in platelet function disorders - identification of new variant of P2Y12, TxA2 and GPVI receptors. Hamostaseologie (2010) 0.84
A modified HPLC technique for simultaneous measurement of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in cerebrospinal fluid, platelet and plasma. Life Sci (1990) 0.82
Platelet secretion defect in patients with the attention deficit disorder and easy bruising. Blood (1984) 0.82
Molecular determinants of platelet delta storage pool deficiencies: an update. Br J Haematol (2012) 0.81
Adenine and guanine nucleotide metabolism during platelet storage at 22 degrees C. Blood (1990) 0.81
Quantitative and continuous analysis of ATP release from blood platelets with firefly luciferase luminescence. Thromb Haemost (1985) 0.81
What's new in using platelet research? To unravel thrombopathies and other human disorders. Eur J Pediatr (2007) 0.81
A protein phosphorylation-based assay for screening and monitoring of drugs modulating cyclic nucleotide pathways. Anal Biochem (2010) 0.79
Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay. Br J Haematol (2004) 0.79
Polyphosphate multi-tasks. J Thromb Haemost (2012) 0.78
The bleeding child. Part I: primary hemostatic disorders. Eur J Pediatr (2011) 0.77
Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol (2007) 6.15
The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood (2012) 2.47
Decreased renal corin expression contributes to sodium retention in proteinuric kidney diseases. Kidney Int (2010) 2.11
Fluorescent sensors for rapid monitoring of intracellular cGMP. Nat Methods (2006) 1.96
Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice. Cardiovasc Res (2003) 1.51
Real-time monitoring of the PDE2 activity of live cells: hormone-stimulated cAMP hydrolysis is faster than hormone-stimulated cAMP synthesis. J Biol Chem (2004) 1.30
Phosphoproteome of resting human platelets. J Proteome Res (2007) 1.24
Interaction of the plasma membrane Ca2+ pump 4b/CI with the Ca2+/calmodulin-dependent membrane-associated kinase CASK. J Biol Chem (2003) 1.19
Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. Hypertension (2002) 1.16
Actin binding of human LIM and SH3 protein is regulated by cGMP- and cAMP-dependent protein kinase phosphorylation on serine 146. J Biol Chem (2003) 1.16
Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood (2005) 1.15
The natriuretic peptide/guanylyl cyclase--a system functions as a stress-responsive regulator of angiogenesis in mice. J Clin Invest (2009) 1.13
Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase. Biochem Biophys Res Commun (2004) 1.12
Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2003) 1.04
The heart communicates with the endothelium through the guanylyl cyclase-A receptor: acute handling of intravascular volume in response to volume expansion. Endocrinology (2008) 0.99
cGMP and cGMP-dependent protein kinase in platelets and blood cells. Handb Exp Pharmacol (2009) 0.98
Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase. Blood (2003) 0.96
What can proteomics tell us about platelets? Circ Res (2014) 0.95
Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP/cGMP-dependent protein kinase. Blood (2006) 0.93
Volatile anesthetics affect the morphology of rat glioma C6 cells via RhoA, ERK, and Akt activation. J Cell Biochem (2007) 0.92
Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice. Cardiovasc Res (2002) 0.91
Cyclic nucleotide-regulated proliferation and differentiation vary in human hematopoietic progenitor cells derived from healthy persons, tumor patients, and chronic myelocytic leukemia patients. Stem Cells Dev (2008) 0.91
Platelet regulation by NO/cGMP signaling and NAD(P)H oxidase-generated ROS. Blood Cells Mol Dis (2006) 0.91
Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes. Cardiovasc Res (2004) 0.90
L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int (2003) 0.90
Vasodilator-stimulated phosphoprotein-deficient mice demonstrate increased platelet activation but improved renal endothelial preservation and regeneration in passive nephrotoxic nephritis. J Am Soc Nephrol (2005) 0.89
Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways. Blood (2013) 0.87
Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. J Biol Chem (2007) 0.86
Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I. Br J Pharmacol (2003) 0.86
Response: platelet transcriptome and proteome--relation rather than correlation. Blood (2013) 0.86
Low angle light scattering analysis: a novel quantitative method for functional characterization of human and murine platelet receptors. Clin Chem Lab Med (2012) 0.85
Increased sensitivity to endothelial nitric oxide (NO) contributes to arterial normotension in mice with vascular smooth muscle-selective deletion of the atrial natriuretic peptide (ANP) receptor. J Biol Chem (2003) 0.83
Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation. BMC Syst Biol (2011) 0.83
The good, the bad, the ugly: validating the mass spectrometric analysis of modified peptides. Proteomics (2011) 0.83
Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA. J Am Soc Nephrol (2003) 0.82
Roles of cGMP/cGMP-dependent protein kinase in platelet activation. Blood (2004) 0.82
Phosphoproteomics of human platelets: A quest for novel activation pathways. Biochim Biophys Acta (2006) 0.82
Phosphatidylserine surface expression and integrin alpha IIb beta 3 activity on thrombin/convulxin stimulated platelets/particles of different sizes. Br J Haematol (2008) 0.81
Mena/VASP and αII-Spectrin complexes regulate cytoplasmic actin networks in cardiomyocytes and protect from conduction abnormalities and dilated cardiomyopathy. Cell Commun Signal (2013) 0.81
Quantitative differential proteome analysis in an animal model for human melanoma. J Proteome Res (2009) 0.81
Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclase. Br J Pharmacol (2013) 0.81
Integrin-dependent translocation of LASP-1 to the cytoskeleton of activated platelets correlates with LASP-1 phosphorylation at tyrosine 171 by Src-kinase. Thromb Haemost (2009) 0.79
L-Arginine does not affect renal morphology and cell survival in ischemic acute renal failure in rats. Nephron Physiol (2005) 0.79
Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.78
Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy. J Transl Med (2012) 0.78
Differential roles of cAMP and cGMP in megakaryocyte maturation and platelet biogenesis. Exp Hematol (2012) 0.78
Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling. Proteomics (2013) 0.78
The Thr715Pro variant impairs terminal glycosylation of P-selectin. Thromb Haemost (2012) 0.77
Prostaglandin E2 inhibits vasotocin-induced osmotic water permeability in the frog urinary bladder by EP1-receptor-mediated activation of NO/cGMP pathway. Am J Physiol Regul Integr Comp Physiol (2007) 0.77
Frog urinary bladder epithelial cells express TLR4 and respond to bacterial LPS by increase of iNOS expression and L-arginine uptake. Am J Physiol Regul Integr Comp Physiol (2012) 0.77
Inhibition of platelet P2Y12 and alpha2A receptor signaling by cGMP-dependent protein kinase. Biochem Pharmacol (2002) 0.77
Neisseria meningitidis induces platelet inhibition and increases vascular endothelial permeability via nitric oxide regulated pathways. Thromb Haemost (2011) 0.76
Dynamical modelling of prostaglandin signalling in platelets reveals individual receptor contributions and feedback properties. Mol Biosyst (2013) 0.76
A Boolean view separates platelet activatory and inhibitory signalling as verified by phosphorylation monitoring including threshold behaviour and integrin modulation. Mol Biosyst (2013) 0.76
Human blood platelets lack nitric oxide synthase activity. Platelets (2014) 0.76
Does the NO/sGC/cGMP/PKG pathway play a stimulatory role in platelets? Blood (2012) 0.76
The thrombin inhibitors hirudin and Refludan(®) activate the soluble guanylyl cyclase and the cGMP pathway in washed human platelets. Thromb Haemost (2012) 0.76
Immune escape of AKT overexpressing ovarian cancer cells. Int J Oncol (2013) 0.75
Potential pitfalls with the use of acetoxy (CH(3)COO) drugs in studies on nitric oxide synthase in platelets. Nitric Oxide (2012) 0.75
A comparative analysis of the bistability switch for platelet aggregation by logic ODE based dynamical modeling. Mol Biosyst (2014) 0.75
Alterations of the platelet proteome in type I Glanzmann thrombasthenia caused by different homozygous delG frameshift mutations in ITGA2B. Thromb Haemost (2017) 0.75